Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S.

Neuralink, the Elon Musk-owned brain-computer interface company, has received "breakthrough device" clearance from the FDA.

Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device.

To increase solar adoption across the globe, researchers have developed an innovative hybrid device that aims to address the ...

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind ...

The FDA approval given to Musk's start-up Neuralink allows for human testing. A look at how Blindsight works & Neuralink’s ...

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology ...

Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S.

The US FDA has awarded breakthrough device status to Neuralink's Blindsight, an experimental implant designed to restore ...

Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision ...